ADLM
In Brief This Week: Bruker, Qiagen, Prenetics, CellChorus, T2 Biosystems, More
News items for the week of Oct. 7, 2024.
The rule could force labs to shed tests deemed nonessential to their institutions' missions as well as influence decisions around instrumentation and vendor choices.
At the ADLM annual meeting, firms said they see game-changing opportunities for platforms that provide the right combination of clinical utility and convenience.